Skip to main content

Share story

AI Infrastructure

Google makes Cloud Pathways generally available for TPU workloads

Google makes Cloud Pathways generally available for TPU workloads Image: Primary
Google has made Cloud Pathways generally available on Google Kubernetes Engine, giving cloud customers a runtime that coordinates thousands of TPU chips through a single JAX client process. Google says Pathways users processed more than 130 million Cloud TPU chip-hours over the last 90 days. The runtime lets training jobs resize across remaining TPU slices after hardware failures, using snapshots stored in host memory. Python containers running alongside workloads handle tasks such as data loading and checkpointing. Availability covers regions supporting TPU v5e, v5p, Trillium and Ironwood on GKE, with JAX 0.10.1+. Integration with Slurm clusters through Cluster Director remains in Preview.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Cloud Blog and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.